Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MYOLYN and Brooks Rehabilitation Formalize Decade-Long Collaboration to Drive the Next Generation of Rehabilitation


News provided by

MYOLYN

Jul 28, 2026, 07:55 ET

Share this article

Share toX

Share this article

Share toX


Newly structured partnership will accelerate patient-centered device development, clinical research, and expanded access for people living with neurological injuries or illness.

GAINESVILLE and JACKSONVILLE, Fla., July 28, 2026 /PRNewswire-PRWeb/ -- MYOLYN, a medical technology company dedicated to making functional electrical stimulation (FES) therapy more accessible, today announced a formal partnership with Brooks Rehabilitation, Florida's top-ranked rehabilitation hospital according to the U.S. News & World Report. The agreement builds on ten years of collaborative work and establishes a structured framework for advancing rehabilitation technology that serves people living with neurological injuries or illness.

At the heart of the partnership is MYOLYN's FES therapy technology, including the MyoCycle FES cycling therapy system — a device designed to be affordable, intuitive, and effective for both clinical and home settings. Brooks Rehabilitation brings more than five decades of expertise in complex rehabilitation care, including treatment of spinal cord and brain injuries, stroke, multiple sclerosis, traumatic amputations, and multi-trauma conditions, along with a national reputation for clinical innovation and outcomes-driven research.

"This partnership reflects what we've known for years: the best rehabilitation technology is developed alongside the patients and clinicians who depend on it. MYOLYN has consistently demonstrated a commitment to listening — to understanding what our patients need in the clinic and at home."

Post this

"This partnership reflects what we've known for years: the best rehabilitation technology is developed alongside the patients and clinicians who depend on it. MYOLYN has consistently demonstrated a commitment to listening — to understanding what our patients need in the clinic and at home, not just what is technically feasible. Formalizing this relationship gives us the structure to share clinical insights more systematically and to pursue the kind of rigorous research that moves the field forward for people living with neurological injuries or illness."

— Robert McIver, PT, DPT, NCS, Director of the Center for Innovation, Brooks Rehabilitation

Under the terms of the partnership, MYOLYN will draw on Brooks' clinical knowledge and patient feedback to guide the research and development of its medical devices. The two organizations will also collaborate on funding applications for clinical investigations examining the benefits of MYOLYN's technology for Brooks Rehabilitation patients. By embedding clinical expertise directly into the development process, both organizations aim to produce solutions that are meaningfully responsive to real-world needs — not just technically sound, but safe, effective, and accessible.

"Developing safe and effective rehabilitation technology is impossible without a clear understanding of the needs of both patients and clinicians. We have been working with Brooks Rehabilitation for 10 years now, and we are ecstatic to finally formalize our partnership. With this agreement, we have another direct line of communication between world-class rehabilitation professionals and our innovative development team, which will help ensure that our products are safe, effective, and accessible with minimal risks."

— Matthew Bellman, Ph.D., Co-Founder and Chief Technology Officer, MYOLYN

Brooks' Center for Innovation has been a key partner in MYOLYN's device development since the earliest stages. Within their Neuro Recovery Center, a state-of-the-art neurorehabilitation facility that provides access to specialized equipment after traditional therapy ends, they supported clinical testing and consulting of both the first and second versions of the MyoCycle system. That ongoing collaboration has provided MYOLYN's engineering team with the direct clinical feedback needed to refine each iteration of the device and support new product development.

About Brooks Rehabilitation

Brooks Rehabilitation, a nonprofit headquartered in Jacksonville, Fla., has been a comprehensive system of care for physical rehabilitation for more than 50 years. Ranked by U.S. News & World Report as the best rehabilitation hospital in Florida and top 20 in the nation, Brooks operates three inpatient hospitals in Florida and will open a new hospital on the Mayo Clinic campus in Phoenix, Arizona, in 2026. Through its commitment to innovation, Brooks is at the forefront of cutting-edge research, education and technology advancing the science of rehabilitation. Brooks provides outpatient services in more than 50 locations, offers home health care, skilled nursing, assisted living and memory care along with community programs and services to improve the quality of life for people living with physical disabilities.

About MYOLYN

MYOLYN's mission is to improve health and human performance by empowering people to move. Millions of people experience serious health consequences as a result of limited mobility — a reality both of MYOLYN's founders have witnessed firsthand through loved ones facing mobility challenges. Driven by that experience, MYOLYN is committed to making advanced neurorehabilitation technology available to people in both home and clinical settings, removing barriers of cost, complexity, and access that have historically kept these tools out of reach.

Media Contact

Press Inquiries, MYOLYN, 1 352-204-9066, [email protected], https://myolyn.com

Twitter, LinkedIn

SOURCE MYOLYN

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.